Plasma calprotectin as a biomarker of mortality at antiretroviral treatment initiation in advanced HIV - pilot study. (2020)

First Author: Kamau FW
Attributed to:  Mechanisms underlying enhanced infection prophylaxis for advanced HIV in Africa funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.15563.2

PubMed Identifier: 33336080

Publication URI: http://europepmc.org/abstract/MED/33336080

Type: Journal Article/Review

Volume: 5

Parent Publication: Wellcome open research

ISSN: 2398-502X